Blue Horseshoe Stocks: LULU Update

Good Morning Traders!

As a result of experiencing technical difficulties in our offices today, we were unable to complete this morning’s premarket report in a timely fashion. Therefore, all we have for you today are the figures on our options idea for LULU from yesterday’s report.

We apologize for the inconvenience, and will return as normal on Monday morning. Thank you for understanding, and good luck out there traders!

-Your Friends at BlueHorseshoeStocks.com


Lululemon Athletica LULU – Update

LULU Weekly $72.50-74 Calls
$72.50 Calls – Range: 1.03-1.84 – Max Gain: 79%
$73 Calls – Range: .81-1.60 – Max Gain: 98%
$73.50 Calls – Range: .65-1.20 – Max Gain: 85%
$74 Calls – Range: .41-1.02 – Max Gain: 149%


Extended Watchlist:
EVH, HMNY, VNET, MYSZ, TEUM, CLDR, VHI, OLED

Blue Horseshoe Stocks: Options Roundup & More

Options Review

Apple, Inc. AAPL  – AAPL beat on earnings as well as kicking off sales on the iPhone X, and two out of three of the AAPL Weekly $170-175 Calls* we signaled for possible daytrades ended up recording some nice moves on the day.

Our first order of business to kick off the fresh week is to recap those moves followed by another set of winners we chose on Friday.

The AAPL $170 Calls ran from 1.63-3.82 for potential gains of up to 135%, while the , $172.50s made an even nicer move from .31 to 1.36 for an intraday rip of 339%

____

Arista Networks, Inc. ANET  - The set of ideas we formulated for ANET on Friday were the 11/17 $195-210 Calls, and all three sets of contracts in that range provided traders with the chance at multi-bag intraday gains.

$195 Calls – Range: 3.15-9.30 – Max Gain: 195%
$200 Calls – Range: 2.40-5.80 – Max Gain: 142%
$210 Calls – Range: 1.00-2.11 – Max Gain: 111%

____

Fresh Idea:

For a new potential play, we’re looking at Pandora Media, Inc. P which took a gut punch on Friday, falling to its lowest prices since early this summer. The last time the stock was this oversold, it followed it up with a run from 6.75 to to 10.00.

We’re going to go out a couple of months on the expiration and track the  P 01/19 $6 and $7 Calls so we have plenty of time to see Pandora make the rebound we’re after.


Keryx Biopharmaceuticals, Inc. KERX

We’re going to put KERX on watch after noticing multiple ripe indicators this morning. The stock bounced of a recent bottom and close with strength at the 200DMA on Friday. With the MACD gearing up for a bullish cross and the RSI just about to crack the 50-line, we’ll be interested to track the activity in KERX in coming sessions.


Extended Watchlist:
HMNY, EVEP, KORS, PTN, AMD, EGLT, NTES

Blue Horseshoe Stocks: CAT Breakout & More

PetMed Express, Inc. PETS

We signaled a longer-term options idea for PETS yesterday which needs some time to ripen, but with the solid move in the stock itself, we figured we’d recap its performance since our initial alert on it six weeks ago.

We caught PETS at a low of 32.90, which makes its 43% run to 46.94 this week that much more impressive. For a thirty-dollar stock to gain more than a third of its value in a matter of just a few weeks, is no small feat.

We’ll continue to keep our selected options, the PETS 11/17 $40-50 Calls on watch over the next few weeks.


Caterpillar, Inc. CAT

Speaking of high dollar stocks that we’ve alerted and then gone on to see impressive gains, we’ve got CAT in our sights again this morning after a solid earnings beat. We’re going to want to highlight some options ideas here as well, but first, let’s talk about the incredible bullish run of Caterpillar this year.

We were talking about this stock back in March, and that same month, the stock traded for as little as 90.34, and has essentially been in a continual uptrend ever since. Measured to this morning’s new premarket high of 141.98, it represents an increase of 57% in just over six months.

As for the options we’ll want to track on the heels of CAT’s earnings beat this morning, we’ll be looking at the CAT Weekly $136-141 Calls.


Atossa Genetics, Inc. ATOS

We’d also like to quickly recap the respectable intraday performance recorded by ATOS following our alert on the stock yesterday morning.

From an early low of .50, ATOS ran to .636 for a solid 27% move which came on more than three times the monthly average volume.

On a side note, the company has also announced that it will hold a conference call tomorrow morning at 10am EDT to discuss preliminary results from the Phase I study of its proprietary oral Endoxifen, an active metabolite of the FDA-approved breast cancer drug tamoxifen. The conference call will be available through a live webcast at www.atossagenetics.com so we’ll be sure to tune in for that.


Extended Watchlist:
HMNY, RCON, ZYNE, KNL, CEMP, DXTR

Blue Horseshoe Stocks: Fresh Options Ideas & More

First we’d like to apologize for our email list members for the absence of yesterday’s premarket report. Our service provider was shut down for the most of the day rendering us unable to send our daily report via email. This is an exceedingly rare event, but in these cases, you can always bookmark and visit BlueHorseshoeStocks.com just before market open, as all of our newsletters are archived there for easy reference.

Alcobra Ltd. ADHD

We did include ADHD in yesterday’s report, but since many of readers happened to miss it, we’ll back up to the next most recent mention, when we alerted the stock on September 29th.

The stock did see sub-1.00 prices that day, but took a couple more sessions to see its low of .96. Since then ADHD has been on a steady run-up, culminating in a new high of 2.17, which represented a very nice 127% move in a three week period.


PayPal Holdings, Inc. PYPL

We want to highlight a range of options for PYPL after the company posted its quarterly earnings after market close yesterday. The stock has been on a nearly continual rise all year long, and in premarket trading today, PYPL shares have rocketed into blue skies, setting a new annual high with each uptick.

As we often do in these post-earnings beat gap-up situations, we’ll identify a set of options contracts in the PYPL chain to observe as things kick off this morning, in this case, the PYPL Weekly $71-72.50 Calls* for potential quick strike trades today.

*Important: Never trade options with a weekly expiration on a Friday unless you’re an expert trader with disposable funds. It’s extremely risky.



AcelRx Pharmaceuticals, Inc. ACRX

ACRX recently fell off a cliff after the FDA rejected the company’s NDA for its Dsuvia drug, however ACRX believes it can meet the accompanying guidelines to eventually submit a successful application. We did alert that event in last Friday’s report, and meanwhile, the stock is gapping up this morning after having seen and bounced off of new annual lows yesterday. 

Recovering even a fraction of the ground it lost last week, could spell significant upswings for ACRX in coming sessions.


Extended Watchlist:
 AUPH, GALT, HMNY, INFI, ONVO, NEOT, BAC,

Blue Horseshoe Stocks: CASI, BYOC, HMNY Recaps

Beyond Commerce, Inc. BYOC

It was the morning of September 25th that we tagged BYOC for observation and it has essentially undergone a continual uptrend over that time period.

That morning we witnessed a low of .0035 in the stock and as of yesterday’s new high reached just prior to the close, was .0189. That amounts to a very impressive boost of 440% over a time span of just 13 trading days.


CASI Pharceuticals, Inc. CASI

We placed CASI on watch in yesterday morning’s premarket report, and wanted to come back this morning to talk about its performance. The stock ran extremely hard out of the starting gate and attainted its high within the first half hour of trading.

Despite failing to maintain its gains into the close, the run it made was impressive nonetheless. CASI’s low came in at 2.82 and it reached as high as 4.84, for an intraday pop of 92%


Helios & Matheson Analytics, Inc. HMNY

We also want to take a final look at the overall move HMNY has made for us. It appears as if its epic run is over but it brought with it one of the biggest, fastest moves we’ve ever seen in a stock in its price range.

From our observed low of 5.47 subsequent to our alert on the stock on September 20th, to yesterday’s mind-bending high of 38.86, represents a rise of 610% Congratulations to anyone who was able to take this one for a ride.


Extended Watchlist:
ONCS, ACLS, ZSAN, INFI, ARDX, CLNT, LTBR